Search research articles
Contact Us
Filters
Showing results (121-130 of 230) with videos related to
Page
of 23
Sort By:
Journal of Clinical Psychopharmacology
|
March 18, 2008
Aripiprazole efficacy in irritability and disruptive-aggressive symptoms: young mania rating scale line analysis from two, randomized, double-blind, placebo-controlled trials
Mark A Frye, James Eudicone, Andrei Pikalov, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
|
June 12, 2010
Anaphylaxis in Israel: experience with 92 hospitalized children
V Hoffer, O Scheuerman, N Marcus, et al.
Schizophrenia Research
|
November 29, 2008
Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study
Matthew J Byerly, Ronald N Marcus, Quynh-Van Tran, et al.
Annals of Surgery
|
October 1, 1987
Experimental and clinical results with proximal end-to-end duodenojejunostomy for pathologic duodenogastric reflux
T R DeMeester, K H Fuchs, C S Ball, et al.
BMC Research Notes
|
February 15, 2022
Primary hypothyroidism and chronotypes in adult women
Marilyn A Arosemena, Alberto R Ramos, Erin N Marcus, et al.
The Journal of Clinical Psychiatry
|
March 6, 2007
Aripiprazole for treatment-resistant schizophrenia: results of a multicenter, randomized, double-blind, comparison study versus perphenazine
John M Kane, Herbert Y Meltzer, William H Carson, et al.
Cancer Genetics and Cytogenetics
|
October 1, 1987
Familial polyposis coli and neurofibromatosis in the same patient: a family study
H T Lynch, R J Fitzgibbons, S J Lanspa, et al.
Journal of Biological Rhythms
|
August 14, 1999
Nocturnal increase in plasma cGMP levels in humans
I V Zhdanova, M Simmons, J N Marcus, et al.
Journal of Affective Disorders
|
February 24, 2009
The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials
Ira D Glick, Raymond Mankoski, James M Eudicone, et al.
CNS Spectrums
|
September 2, 2006
The efficacy and safety of lower doses of aripiprazole for the treatment of patients with acute exacerbation of schizophrenia
Andrew J Cutler, Ronald N Marcus, Sterling A Hardy, et al.
Page
of 23
Search research articles
Search
Showing results (121-130 of 230) with videos related to
Sort By:
Page
of 23
Journal of Clinical Psychopharmacology
|
March 18, 2008
Aripiprazole efficacy in irritability and disruptive-aggressive symptoms: young mania rating scale line analysis from two, randomized, double-blind, placebo-controlled trials
Mark A Frye, James Eudicone, Andrei Pikalov, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology
|
June 12, 2010
Anaphylaxis in Israel: experience with 92 hospitalized children
V Hoffer, O Scheuerman, N Marcus, et al.
Schizophrenia Research
|
November 29, 2008
Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study
Matthew J Byerly, Ronald N Marcus, Quynh-Van Tran, et al.
Annals of Surgery
|
October 1, 1987
Experimental and clinical results with proximal end-to-end duodenojejunostomy for pathologic duodenogastric reflux
T R DeMeester, K H Fuchs, C S Ball, et al.
BMC Research Notes
|
February 15, 2022
Primary hypothyroidism and chronotypes in adult women
Marilyn A Arosemena, Alberto R Ramos, Erin N Marcus, et al.
The Journal of Clinical Psychiatry
|
March 6, 2007
Aripiprazole for treatment-resistant schizophrenia: results of a multicenter, randomized, double-blind, comparison study versus perphenazine
John M Kane, Herbert Y Meltzer, William H Carson, et al.
Cancer Genetics and Cytogenetics
|
October 1, 1987
Familial polyposis coli and neurofibromatosis in the same patient: a family study
H T Lynch, R J Fitzgibbons, S J Lanspa, et al.
Journal of Biological Rhythms
|
August 14, 1999
Nocturnal increase in plasma cGMP levels in humans
I V Zhdanova, M Simmons, J N Marcus, et al.
Journal of Affective Disorders
|
February 24, 2009
The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials
Ira D Glick, Raymond Mankoski, James M Eudicone, et al.
CNS Spectrums
|
September 2, 2006
The efficacy and safety of lower doses of aripiprazole for the treatment of patients with acute exacerbation of schizophrenia
Andrew J Cutler, Ronald N Marcus, Sterling A Hardy, et al.
Page
of 23